Stepan Company [SCL] vs Innospec [IOSP] Detailed Stock Comparison
Stepan Company
NYSE
Loading...
Innospec
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Stepan Company wins in 12 metrics, Innospec wins in 8 metrics, with 0 ties. Stepan Company appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Stepan Company | Innospec | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.21 | 101.95 | Stepan Company |
| Price-to-Book Ratio | 0.89 | 1.51 | Stepan Company |
| Debt-to-Equity Ratio | 58.20 | 3.79 | Innospec |
| PEG Ratio | 1.01 | -4.11 | Innospec |
| EV/EBITDA | 8.89 | 29.71 | Stepan Company |
| Profit Margin (TTM) | 2.57% | 1.08% | Stepan Company |
| Operating Margin (TTM) | 3.06% | 7.96% | Innospec |
| EBITDA Margin (TTM) | 3.06% | 7.96% | Innospec |
| Return on Equity | 4.77% | 1.55% | Stepan Company |
| Return on Assets (TTM) | 2.05% | 0.53% | Stepan Company |
| Free Cash Flow (TTM) | $39.28M | $122.20M | Innospec |
| Dividend Yield | 2.13% | 1.97% | Stepan Company |
| 1-Year Return | -35.79% | -32.91% | Innospec |
| Price-to-Sales Ratio (TTM) | 0.49 | 1.09 | Stepan Company |
| Enterprise Value | $1.74B | $1.74B | Innospec |
| EV/Revenue Ratio | 0.77 | 0.97 | Stepan Company |
| Gross Profit Margin (TTM) | 12.09% | 28.02% | Innospec |
| Revenue per Share (TTM) | $99 | $72 | Stepan Company |
| Earnings per Share (Diluted) | $2.54 | $0.77 | Stepan Company |
| Beta (Stock Volatility) | 0.96 | 1.02 | Stepan Company |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Stepan Company vs Innospec Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Stepan Company | -1.93% | -1.35% | -1.35% | -19.35% | -3.14% | -23.82% |
| Innospec | -3.11% | -2.95% | -8.69% | -14.50% | -15.12% | -29.12% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Stepan Company | -35.79% | -49.18% | -58.16% | 4.49% | 52.84% | 305.13% |
| Innospec | -32.91% | -14.64% | 10.92% | 43.62% | 362.08% | 893.36% |
News Based Sentiment: Stepan Company vs Innospec
Stepan Company
News based Sentiment: POSITIVE
Stepan Company delivered strong Q2 results and provided a positive earnings outlook, leading to a stock price increase and reaffirming its commitment to shareholder returns through consistent dividend growth. While institutional selling is a factor, the overall narrative is positive, suggesting continued growth potential.
Innospec
News based Sentiment: NEUTRAL
The announcement of an earnings release date is a standard practice and doesn't inherently signal positive or negative performance. It's a procedural update that sets the stage for a more substantial information release on November 4th and 5th, 2025, making it moderately important for investors to be aware of.
Performance & Financial Health Analysis: Stepan Company vs Innospec
| Metric | SCL | IOSP |
|---|---|---|
| Market Information | ||
| Market Cap | $1.11B | $1.97B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 166,590 | 243,158 |
| 90 Day Avg. Volume | 190,690 | 217,616 |
| Last Close | $47.20 | $73.92 |
| 52 Week Range | $44.23 - $82.08 | $73.72 - $128.35 |
| % from 52W High | -42.50% | -42.41% |
| All-Time High | $139.30 (May 10, 2021) | $133.71 (May 06, 2024) |
| % from All-Time High | -66.12% | -44.72% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.01% |
| Quarterly Earnings Growth | 0.19% | -0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.01% |
| Operating Margin (TTM) | 0.03% | 0.08% |
| Return on Equity (TTM) | 0.05% | 0.02% |
| Debt to Equity (MRQ) | 58.20 | 3.79 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $54.90 | $52.03 |
| Cash per Share (MRQ) | $3.93 | $10.74 |
| Operating Cash Flow (TTM) | $109.13M | $136.80M |
| Levered Free Cash Flow (TTM) | $-18,496,500 | $-62,687,500 |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.13% | 1.97% |
| Last 12-Month Dividend | $1.16 | $1.63 |
Valuation & Enterprise Metrics Analysis: Stepan Company vs Innospec
| Metric | SCL | IOSP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.21 | 101.95 |
| Forward P/E | 11.99 | 12.54 |
| PEG Ratio | 1.01 | -4.11 |
| Price to Sales (TTM) | 0.49 | 1.09 |
| Price to Book (MRQ) | 0.89 | 1.51 |
| Market Capitalization | ||
| Market Capitalization | $1.11B | $1.97B |
| Enterprise Value | $1.74B | $1.74B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.77 | 0.97 |
| Enterprise to EBITDA | 8.89 | 29.71 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 1.02 |
| Book Value per Share (MRQ) | $54.90 | $52.03 |
Financial Statements Comparison: Stepan Company vs Innospec
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SCL | IOSP |
|---|---|---|
| Revenue/Sales | $594.69M | $440.80M |
| Cost of Goods Sold | $522.80M | $315.70M |
| Gross Profit | $71.89M | $125.10M |
| Research & Development | $14.70M | $12.70M |
| Operating Income (EBIT) | $17.97M | $43.00M |
| EBITDA | $48.20M | $54.10M |
| Pre-Tax Income | $13.79M | $44.40M |
| Income Tax | $2.45M | $11.60M |
| Net Income (Profit) | $11.34M | $32.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SCL | IOSP |
|---|---|---|
| Cash & Equivalents | $88.90M | $299.80M |
| Total Current Assets | $914.77M | $977.10M |
| Total Current Liabilities | $677.83M | $357.60M |
| Long-Term Debt | $433.34M | $30.40M |
| Total Shareholders Equity | $1.24B | $1.27B |
| Retained Earnings | $1.29B | $1.06B |
| Property, Plant & Equipment | $2.77B | $321.50M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SCL | IOSP |
|---|---|---|
| Operating Cash Flow | $39.93M | $21.70M |
| Capital Expenditures | N/A | $100,000 |
| Free Cash Flow | $-14.41M | $12.70M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-4.80M |
Short Interest & Institutional Ownership Analysis
| Metric | SCL | IOSP |
|---|---|---|
| Shares Short | 398,886 | 334,515 |
| Short Ratio | 2.08 | 2.01 |
| Short % of Float | 0.03% | 0.02% |
| Average Daily Volume (10 Day) | 166,590 | 243,158 |
| Average Daily Volume (90 Day) | 190,690 | 217,616 |
| Shares Outstanding | 22.50M | 24.96M |
| Float Shares | 21.44M | 24.52M |
| % Held by Insiders | 0.05% | 0.01% |
| % Held by Institutions | 0.86% | 1.00% |
Dividend Analysis & Yield Comparison: Stepan Company vs Innospec
| Metric | SCL | IOSP |
|---|---|---|
| Last 12-Month Dividend | $1.16 | $1.63 |
| Last 12-Month Dividend Yield | 2.13% | 1.97% |
| 3-Year Avg Annual Dividend | $1.36 | $1.48 |
| 3-Year Avg Dividend Yield | 0.43% | 0.70% |
| 3-Year Total Dividends | $4.08 | $4.45 |
| Ex-Dividend Date | Mar 03, 2025 | May 20, 2025 |